Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 April 2024 | Story DR NITHA RAMNATH

The Vice-Chancellor and Principal of the University of the Free State, Prof Francis Petersen, has the pleasure of inviting you to a guest lecture presented by H.E. Dr Reuben E Brigety, the United States Ambassador to South Africa.

Date: Tuesday 23 April 2024
Time: 15:00-16:00
Venue: Centenary Complex, Bloemfontein Campus

RSVP here by no later than 19 April 2024.


About the speaker

Reuben E Brigety II was confirmed as the 29th United States Ambassador to the Republic of South Africa on 21 July 2022.

Previously, he served as the 17th Vice-Chancellor of the University of the South and Mayor of Sewanee from June 2020 until December 2021, and as the Dean of the Elliott School of International Affairs of the George Washington University from 2015 to 2020. Ambassador Brigety’s most recent diplomatic assignment was serving as the US Representative to the African Union and US Permanent Representative to the UN Economic Commission for Africa from September 2013 to September 2015. Previously, Ambassador Brigety served as the Deputy Assistant Secretary of State in the Bureau of African Affairs and as Deputy Assistant Secretary of State in the Bureau of Population, Refugees, and Migration.

A native of Jacksonville, Florida, Ambassador Brigety also held appointments as Assistant Professor of Government and Politics at George Mason University and at the School of International Service at the American University between August 2003 and April 2009. In addition, Ambassador Brigety was a researcher with the Arms Division of Human Rights Watch (HRW) from August 2001 to May 2003, where he conducted research missions in Afghanistan and Iraq. Before joining HRW, Ambassador Brigety was an active-duty US naval officer and held several staff positions in the Pentagon and in fleet support units.

Ambassador Brigety is a 1995 Distinguished Midshipman Graduate of the US Naval Academy, where he earned a BSc in Political Science (with merit), served as the Brigade Commander, and received the Thomas G Pownall Scholarship. He also holds an MPhil and a PhD in International Relations from the University of Cambridge, England, as well as a Doctor of Humane Letters (honoris causa) from Old Dominion University. Ambassador Brigety is a life member of the Council on Foreign Relations, a recipient of the council’s International Affairs Fellowship, and a fellow of the American Academy of Diplomacy.He is married to Dr Leelie Selassie, and together they have two sons.

News Archive

Chakalaka can have side effects for these patients
2010-06-24

Chakalaka is a sauce many South Africans cannot imagine a meal without, but research at the Faculty of Health Sciences at the University of the Free State (UFS) has shown that it can have serious side effects and even compromise the treatment of leukaemia patients.

Prof. Vernon Louw from the Department of Internal Medicine at the Faculty says that tyrosine kinase inhibitors (TKIs) are a new group of drugs providing targeted therapy for chronic myeloid leukaemia (CML). It vastly contributes to the survival of patients, but it has side effects like vasodilatation. Research has shown that spices like chakalaka may aggravate vasodilatation (widening of veins) with patients on these drugs.

“These spices produce serious oedema (water retention) and headaches. We have found that discontinuing the intake of spices allows some patients to maintain therapeutic doses of TKIs.” Chakalaka contains mainly garlic and chilli.

CML represents up to 20% of all leukaemia patients in South Africa and up to 450 new cases are reported every year.

In the study symptoms of severe headache and oedema disappeared within days of discontinuing the use of chakalaka.

Prof. Louw says it is important for oncologists to ask their patients about their intake of spices and garlic when they are on TKIs. It is also advisable to enquire about the use of complementary alternative medicine as the interaction of these medicines in cancer treatment is not known.

Media Release

Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za
23 June 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept